Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Breast 2

Conditions

Breast Neoplasms 33Lymphoma 25Lymphoma, Large B-Cell, Diffuse 19Lymphoma, Non-Hodgkin 12Leukemia 9Hodgkin Disease 9Burkitt Lymphoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Multiple Myeloma 8Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 7Sarcoma 6Neoplasms 6Leukemia, Lymphocytic, Chronic, B-Cell 6Triple Negative Breast Neoplasms 5Neutropenia 5Lymphoma, B-Cell, Marginal Zone 5Central Nervous System Neoplasms 5Urinary Bladder Neoplasms 4Prostatic Neoplasms 4Osteosarcoma 4Lung Neoplasms 4Waldenstrom Macroglobulinemia 3Testicular Neoplasms 3Sarcoma, Ewing 3Rhabdomyosarcoma 3Neuroblastoma 3Neoplasm Metastasis 3

Interventions

Meropenem 5Ceftazidime 4Levofloxacin 3Filgrastim 3Ciprofloxacin 3Cefepime 3Amikacin 3pegfilgrastim 2Vancomycin 2Interleukin 1 Receptor Antagonist Protein 2Anti-Bacterial Agents 2Amoxicillin-Potassium Clavulanate Combination 2pegylated granulocyte colony-stimulating factor 1Therapeutics 1Teicoplanin 1Tazobactam 1TKN732 1Surveys and Questionnaires 1Positron Emission Tomography Computed Tomography 1Piperacillin 1Ofloxacin 1NF protocol 1Micafungin 1Metronidazole 1Magnetic Resonance Myelography 1Lead 1Injections 1Granulocyte Colony-Stimulating Factor 1Cloxacillin 1Cilastatin, Imipenem Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Febrile Neutropenia × pegfilgrastim × Clear all
NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Asan Medical Center

Phase 2 Terminated
22 enrolled
BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT00536081 2019-11-06

Various G-CSF Regimens to Prevent Infection During Chemotherapy

Academisch Ziekenhuis Maastricht

Phase 3 Completed
172 enrolled
BreastClassical hematology

Breast Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡